Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Voyager Therapeutics Inc
VT6Current price
6.73 EUR
+0.26 EUR (+4.02%)
Last closed
6.69 USD
Company
www.voyagertherapeutics.com
ISIN
US92915B1061
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
388 822 432 USD
Yield for 12 month
-7.58 %
1Y
3Y
5Y
10Y
15Y
VT6
Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts. Address: 75 Hayden Avenue, Lexington, MA, United States, 02421
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
17.33 USDP/E ratio
26.4074Dividend Yield
–Current Year
+250 008 000 USD
Last Year
+40 907 000 USD
Current Quarter
+29 578 000 USD
Last Quarter
+19 516 000 USD
Current Year
+245 567 000 USD
Last Year
+40 907 000 USD
Current Quarter
+28 186 000 USD
Last Quarter
+18 320 000 USD
Key Figures VT6
1 year
3 years
5 years
10 years
EBITDA
-1 784 000 USD
Operating Margin TTM
PE Ratio
26.4074
Return On Assets TTM
-1.11 %
PEG Ratio
–
Return On Equity TTM
3.38 %
Wall Street Target Price
17.33 USD
Revenue TTM
143 768 992 USD
Book Value
6.16 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
509.5 %
Dividend Yield
–
Gross Profit TTM
-19 857 000 USD
Earnings per share
0.27 USD
Diluted Eps TTM
0.27 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
6.28 %
Dividend Analytics VT6
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VT6
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation VT6
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
26.4074
Forward PE
–
Enterprise Value Revenue
0.4503
Price Sales TTM
2.7045
Enterprise Value EBITDA
2.5901
Price Book MRQ
1.1592
Financials VT6
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VT6
For 52 weeks
5.71 USD
11.72 USD
50 Day MA
6.6 USD
Shares Short Prior Month
2 986 924
200 Day MA
7.84 USD
Short Ratio
5.96
Shares Short
3 447 259
Short Percent
7.54 %
BeatStart